Article

Treatments for Female Hair Loss

Written by Dody Gasparik

Topic: Health Products and ServicesPublished May 27, 2009
No ratings yet1,968 viewsSign in to rate

Hair loss can be caused by a different variety of factors but genetics is the number one reason why men and women lose their mane. Hereditary hair loss in men and women has the same main cause, which is dihydrotestosterone (DHT) attacking our hair follicles. DHT is a metabolite of the male hormone testosterone but it is also present in the female body. Men and women lose their hair not because of increased levels of DHT in their bodies but due to the vulnerability of their hair follicles to DHT attacks, although the exact mechanism and reasons why certain hairs, mostly those on the top of the head, are more vulnerable to such attacks are not yet know.

The principal difference between the male and female form of hereditary baldness is in its shape. The male form has a characteristic horseshoe pattern whereas the female form is usually a diffuse thinning across the entire scalp and is therefore less easily-recognised. The female form of hereditary hair loss is, in its form, practically indistinguishable from hair loss caused by various other factors. The second most common reason for a woman to lose her hair is hormonal imbalances during and after pregnancy or menopause. Such changes are typically of a temporary nature and so also is the hair loss, although post-menopausal hair loss is in most cases permanent.

When it comes to treating hair loss in women there are some specifics. First, most women do not make very good candidates for hair transplantation due to their diffuse thinning pattern, which makes it impossible to identify the hair that will be resistant to future miniaturisation. Secondly, finasteride, which is one of the only two FDA-approved hair loss treatments available today, cannot be used on women and neither can dutasteride, which is its closest relative. Rogaine (generic name minoxidil) is the second FDA-approved hair loss treatment and its approved concentration for women is only 2% versus 5% for men. However, many doctors recommend their female patients use 5% minoxidil formulations such as Rogaine foam. Aminexil is a molecule similar to minoxidil and it is often recommended to women who are pregnant or breastfeeding as a safer option than minoxidil.

Although some anti-androgens such as finasteride or dutasteride cannot be prescribed to female patients, there are other anti-androgen medications that can be effectively used to treat female hair loss. Spironolactone (trade name Aldactone) and cyproterone acetate (used in contraceptives such as Diane 35, Diane 50 and Ginette 35) are anti-androgens most commonly used to treat female pattern baldness.

Another treatment with seemingly high rates of success is topical estrogen solutions such as Crinohermal, which use a female hormone, estradiol, as their main active substance. Estradiol is capable of inhibiting the conversion of testosterone into follicle-harming DHT. Hormone replacement therapy is another hormonal treatment suitable for women at menopause, with estrogens and progesterone pills and creams being the most common forms of treatment. Estrogen levels in the body decline with time. As women enter the menopause, estrogen levels decline and, therefore, more of the male hormone testosterone is then available to be converted into follicle-harming DHT.

The above list of treatments for female hair loss is not exhaustive, though. There are a number of other remedies that are often claimed to help promote hair growth in women, such as ketoconazole, flutamide, fluridil, alfatradiol, as well as various substances of natural origin. Despite the fact that there are female patients who will swear by some of these treatments, none of them has ever been sufficiently clinically tested, let alone approved by any major national health supervisory authority as a treatment for female baldness and the claims of their guaranteed effectiveness should be taken with a grain of salt.

Article author

About the Author

For more information on existing women hair loss treatments and how to best identify the most suitable treatment for your current condition please refer to the author's platform dedicated to educating the public on treating premature hair loss and grey hair. You are encouraged to use this platform to share your experiences with the hair treatments you have used.

Further reading

Further Reading

4 total

Article

Discover how to clear out medical clutter and responsibly manage surplus diagnostic tools by exploring practical ways to repurpose excess inventory.

August 14, 2026

Article

Introduction: The Quiet Weight of Extra Medical Supplies In many homes and storage spaces, boxes of diabetic supplies slowly gather dust. They sit on shelves, in closets, and inside cabinets, often forgotten after treatment plans change or new prescriptions replace old ones. What begins as careful preparation for health can gradually become a burden that feels difficult to manage. The presence of extra supplies can create emotional and physical clutter, leaving people unsure

February 9, 2026

Article

The festive season paints our cities with bright lights, vibrant colours, and joy, but along with the sparkle comes smog, smoke, and increased pollution that results in a dull environment and bad air quality and hampers your health as well. Between firecrackers, traffic, and endless celebrations, your body often struggles to keep up. Fatigue, dull skin, and breathing discomfort become common. Glutathione therapy and IV drip therapy are revolutionizing healthcare and wellness,

October 30, 2025

Article

Understanding DBS in Parkinson's Treatment Deep Brain Stimulation (DBS) is an innovative and radical surgical procedure designed to alleviate the symptoms of late-stage Parkinson's disease. This operation is about placing electrodes in certain brain areas that control movement. These electrodes get linked to a small device that sends regulated electrical impulses, which is the main reason for the reduction of tremors, rigidity, and bradykinesia. When there are patients who h

August 21, 2025